Loading insider details...
Beta
Latest Form 4 (Jun 11, 2026): Grant/Award of 77,500 SLDB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Solid Biosciences Inc. (SLDB) | Grant/Award | 77,500 | n/a |
| Jun 10, 2026 | Intellia Therapeutics, Inc. (NTLA) | Grant/Award | 9,200 | n/a |
| Jun 18, 2025 | Intellia Therapeutics, Inc. (NTLA) | Grant/Award | 8,000 | n/a |
| Jun 18, 2025 | Solid Biosciences Inc. (SLDB) | Grant/Award | 77,500 | n/a |
| Jun 14, 2024 | Intellia Therapeutics, Inc. (NTLA) | Grant/Award | 7,737 | n/a |
| Jun 13, 2024 | Solid Biosciences Inc. (SLDB) | Grant/Award | 34,400 | n/a |
| Jun 16, 2023 | Intellia Therapeutics, Inc. (NTLA) | Grant/Award | 4,425 | n/a |
| Jun 9, 2023 | Solid Biosciences Inc. (SLDB) | Grant/Award | 9,650 | n/a |
| Dec 15, 2022 | Solid Biosciences Inc. (SLDB) | Grant/Award | 9,650 | n/a |
| Jun 16, 2022 | Intellia Therapeutics, Inc. (NTLA) | Grant/Award | 5,197 | n/a |